NeuroMetrix Partners with Handok Pharmaceuticals for NC-stat DPNCheck Distribution in the Republic of Korea WALTHAM, Mass. --(BUSINESS WIRE)--Mar. 12, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of

NeuroMetrix Reports Q4 2012 Results WALTHAM, Mass. --(BUSINESS WIRE)--Feb. 19, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and

Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on February 19, 2013

NeuroMetrix, Inc. Announces Date for 2012 Full Year and Fourth Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Feb. 12, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , today said it plans to issue its 2012 full year and fourth quarter financial results

NeuroMetrix Launches Website for SENSUS™ Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Jan. 30, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that is

NeuroMetrix Announces Initial Commercial Shipment of SENSUS™ Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Jan. 7, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes,

NeuroMetrix to Present at 6th Annual OneMedForum San Francisco 2013 WALTHAM, Mass. --(BUSINESS WIRE)--Jan. 2, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced

NeuroMetrix Completes 510(k) Clearance Process for SENSUS™ Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 29, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes,

NeuroMetrix to Present at Canaccord Genuity Medical Technology & Diagnostics Forum WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 27, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes,

NeuroMetrix Announces Distribution Agreement with OneSource Medical Group for SENSUS Pain Management Device WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 1, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of